XML 21 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Operations (Unaudited) (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Product revenues $ 6,744 $ 5,771 $ 12,718 $ 11,573
Service revenues 3,972 1,913 6,015 3,988
Total revenues 10,716 7,684 18,733 15,561
Cost of sales 3,385 2,365 5,680 4,700
Gross profit 7,331 5,319 13,053 10,861
Selling, general and administrative 6,836 4,479 11,587 9,164
Research and development 2,345 1,929 4,125 3,860
Total operating expenses 9,181 6,408 15,712 13,024
Operating loss (1,850) (1,089) (2,659) (2,163)
Interest expense, net (95) (4) (109) (9)
Other loss, net (39) (13) (122) (6)
Loss before taxes (1,984) (1,106) (2,890) (2,178)
Income tax (expense) benefit, net (93) 476 (104) 597
Net loss (2,077) (630) (2,994) (1,581)
Less: Net income attributable to Non controlling interests 8   8  
Net loss attributable to ChyronHego shareholders $ (2,085) $ (630) $ (3,002) $ (1,581)
Net loss per share attributable to ChyronHego shareholders- basic (in Dollars per share) $ (0.09) $ (0.04) $ (0.15) $ (0.09)
Net loss per share attributable to ChyronHego shareholders- diluted (in Dollars per share) $ (0.09) $ (0.04) $ (0.15) $ (0.09)
Basic (in Shares) 22,989 16,898 20,191 16,852
Diluted (in Shares) 22,989 16,898 20,191 16,852